Login / Signup

Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer.

Shinsuke HanawaAkira MitsuhashiMakio Shozu
Published in: PloS one (2018)
This trial is registered with UMIN-CTR (number UMIN000004852).
Keyphrases
  • endometrial cancer
  • phase iii
  • study protocol
  • clinical trial
  • phase ii
  • protein protein
  • amino acid
  • binding protein
  • randomized controlled trial
  • small molecule
  • open label